| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A global perspective of racial differences and outcomes in patients presenting with acute heart failure
|
Tromp, Jasper
|
|
|
243 |
C |
p. 11-14
|
artikel
|
| 2 |
Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients
|
Weaver, Anne M.
|
|
|
243 |
C |
p. 201-209
|
artikel
|
| 3 |
Catheter ablation for persistent atrial fibrillation: A multicenter randomized trial of pulmonary vein isolation (PVI) versus PVI with posterior left atrial wall isolation (PWI) - The CAPLA study
|
Chieng, David
|
|
|
243 |
C |
p. 210-220
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
243 |
C |
p. iii-iv
|
artikel
|
| 5 |
Effect of intensive versus limited monitoring on clinical trial conduct and outcomes: A randomized trial
|
Butala, Neel M.
|
|
|
243 |
C |
p. 77-86
|
artikel
|
| 6 |
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial
|
Tavenier, Anne H.
|
|
|
243 |
C |
p. 39-42
|
artikel
|
| 7 |
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study
|
Arnold, Suzanne V
|
|
|
243 |
C |
p. 232-239
|
artikel
|
| 8 |
Information for Readers
|
|
|
|
243 |
C |
p. v
|
artikel
|
| 9 |
Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction – findings from the LATITUDE–TIMI 60 trial
|
Cavender, Matthew A
|
|
|
243 |
C |
p. 147-157
|
artikel
|
| 10 |
In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging
|
Yin, Yanwei
|
|
|
243 |
C |
p. 66-76
|
artikel
|
| 11 |
Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial
|
Korsholm, Kasper
|
|
|
243 |
C |
p. 28-38
|
artikel
|
| 12 |
Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease
|
Burnham, Tyson S.
|
|
|
243 |
C |
p. 127-139
|
artikel
|
| 13 |
Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program
|
Plutzky, Jorge
|
|
|
243 |
C |
p. 15-27
|
artikel
|
| 14 |
Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia
|
Bainey, Kevin R.
|
|
|
243 |
C |
p. 187-200
|
artikel
|
| 15 |
Prevalent pharmacotherapy of US Fontan survivors: A study utilizing data from the MarketScan Commercial and Medicaid claims databases
|
O'Byrne, Michael L.
|
|
|
243 |
C |
p. 158-166
|
artikel
|
| 16 |
Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial
|
de Koning, Marie-Sophie LY
|
|
|
243 |
C |
p. 167-176
|
artikel
|
| 17 |
Rationale and design of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial)
|
Herrmann, Howard C.
|
|
|
243 |
C |
p. 92-102
|
artikel
|
| 18 |
Rationale and pathways forward in the implementation of coronary artery calcium-based enrichment of randomized trials
|
Cainzos-Achirica, Miguel
|
|
|
243 |
C |
p. 54-65
|
artikel
|
| 19 |
Relationship of ejection fraction and natriuretic peptide trajectories in heart failure with baseline reduced and mid-range ejection fraction
|
Bilchick, Kenneth C.
|
|
|
243 |
C |
p. 1-10
|
artikel
|
| 20 |
Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes
|
Xu, Yang
|
|
|
243 |
C |
p. 177-186
|
artikel
|
| 21 |
Table of Contents
|
|
|
|
243 |
C |
p. i-ii
|
artikel
|
| 22 |
Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: A nationwide study
|
Strange, Jarl E.
|
|
|
243 |
C |
p. 140-146
|
artikel
|
| 23 |
The bleeding risk treatment paradox at the physician and hospital level: Implications for reducing bleeding in patients undergoing percutaneous coronary intervention
|
Amin, Amit P.
|
|
|
243 |
C |
p. 221-231
|
artikel
|
| 24 |
The COVID-19 pandemic and cardiovascular issues in clinical trials: Practical and regulatory issues in remote monitoring of cardiac safety
|
Seltzer, Jonathan
|
|
|
243 |
C |
p. 122-126
|
artikel
|
| 25 |
The importance of the design of observational studies in comparative effectiveness research: Lessons from the GARFIELD-AF and ORBIT-AF registries
|
Farjat, Alfredo E.
|
|
|
243 |
C |
p. 110-121
|
artikel
|
| 26 |
The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives
|
Truong, Dongngan T.
|
|
|
243 |
C |
p. 43-53
|
artikel
|
| 27 |
Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018
|
Salah, Husam M.
|
|
|
243 |
C |
p. 103-109
|
artikel
|
| 28 |
Trends in transcatheter and surgical aortic valve replacement in the United States, 2008-2018
|
Clark, Katherine AA
|
|
|
243 |
C |
p. 87-91
|
artikel
|
Tijdschrift beschrijving